Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines

Author’s reply

  • Langman, M J S
  • Ransford, R A J

  • Queen Elizabeth Medical Centre, Birmingham, UK

Correspondence to: Professor M J S Langman, Department of Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TH, UK; [email protected]

Gut 52(10):p 1530-1531, October 2003.
Copyright © 2003 Gut.
View full text|Download PDF